Paramedical Protocol for Ventilation in Acute Respiratory Distress Syndrome
NCT ID: NCT06039215
Last Updated: 2023-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
540 participants
INTERVENTIONAL
2023-10-01
2025-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Driving Pressure-guided Tidal Volume Ventilation in the Acute Respiratory Distress Syndrome
NCT06322758
ARDSnet Protocol vs. Open Lung Approach in ARDS
NCT00431158
Clinical Decision Support Tool in PARDS Pilot Study
NCT04068012
Pulmonary and Ventilatory Effects of Bed Verticalization in Patients With Acute Respiratory Distress Syndrome
NCT04371016
Ultra-Protective Lung Ventilation With Extracorporeal CO2 Removal for Moderate ARDS
NCT04903262
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
Respirator settings are adjusted by nurses according to a pre-established care protocol that complies with international recommendations. The nurse assesses the patient's respiratory status and readjusts the artificial respirator settings if necessary, at least twice a day.
Ventilatory adjustments by nurses
Respirator settings are adjusted by nurses according to a pre-established care protocol that complies with international recommendations. The nurse assesses the patient's respiratory status and readjusts the artificial respirator settings if necessary, at least twice a day.
Control group
The ventilator settings are adjusted in line with the centre's usual practice. No change from usual management of acute respiratory distress syndrome.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ventilatory adjustments by nurses
Respirator settings are adjusted by nurses according to a pre-established care protocol that complies with international recommendations. The nurse assesses the patient's respiratory status and readjusts the artificial respirator settings if necessary, at least twice a day.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intensive care hospitalization;
* Intubation with artificial ventilation;
* ARDS evolving for less than 72 hours. ARDS criteria according to the Berlin definition, as follows:
* Exposure to a risk factor for ARDS or onset/aggravation of pulmonary symptoms within the previous 7 days ;
* Respiratory distress not fully explained by cardiac failure or volume overload, with exclusion of hydrostatic edema in the absence of exposure to a risk factor for ARDS;
* Hypoxemia with PaO2/FiO2 ratio \< 300 mm Hg under PEEP ≥ 5 cmH2O ;
* Bilateral opacities on chest X-ray, lung ultrasound or chest CT, not fully explained by pleural effusions, atelectasis or nodules.
* Blood pressure monitoring
* Affiliation to the social security system.
* Written informed consent (patient, relative) or inclusion in emergency situation.
Exclusion Criteria
* Pneumothorax or drained pleurisy;
* Documented pulmonary embolism;
* Intracranial hypertension;
* ARDS refractory to inclusion, i.e.: i) oxygen partial pressure on inspired oxygen fraction a ratio (PaO2/FiO2) \<80 mm Hg or plateau pressure (Pplat) \> 32 cmH2O despite optimization of mechanical ventilation (tidal volume (Vt) set at 6 mL/kg weight predicted by height, FiO2 ≥80% and positive expiratory pressure (PEEP) ≥10 cmH2O) and despite the use of complementary therapies (including prone and/or inhaled nitric oxide); or ii) pH \<7. 25 with PaCO2 ≥60 mm Hg;
* ARDS evolving for more than 72 hours with intubation and mechanical ventilation;
* Patient deprived of liberty;
* Patient under legal protection (guardianship or curatorship);
* Known pregnancy or breast-feeding (a pregnancy test will be performed prior to inclusion in patients of childbearing age).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assistance Publique-Hôpitaux de Paris service de santé publique
Créteil, Creteil, France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Assistance Publique-Hôpitaux de Paris service de santé publique
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A02716-37
Identifier Type: OTHER
Identifier Source: secondary_id
APHP191098
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.